We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 315

Lessons learned from first Final Written Decision in a Hatch-Waxman related inter partes review

  • Paul Hastings LLP
  • -
  • USA
  • -
  • December 16 2014

Last week, the Patent Trial and Appeal Board issued Final Written Decisions in three inter partes review proceedings upholding the patentability of

FTC commissioner brill urges Congress to act on patent trolls

  • McDermott Will & Emery
  • -
  • USA
  • -
  • December 15 2014

In a speech at the American Antitrust Association (AAI) and Computer & Communications Industry Association (CCIA) Conference on Innovation, Patents

Made in Canada approach to pay for delay: bureau at odds with US approach

  • Cassels Brock & Blackwell LLP
  • -
  • USA
  • -
  • December 8 2014

Last week, a US Federal Court ruled that AstraZeneca Plc's payment to Ranbaxy Laboratories Ltd. to delay a generic version of heartburn medication

FDA citizen petition may give rise to antitrust liability; factual issues exist concerning whether ANDA infringement claim was objectively baseless

  • Fish & Richardson PC
  • -
  • USA
  • -
  • December 6 2014

Federal Circuit reverses summary judgment of no sham litigation related to an infringement suit and FDA citizen’s petition but affirms summary

FTC settles with patent assertion entity to prevent future deceptive conduct that would trigger penalties of up to $16,000 per letter

  • Akin Gump Strauss Hauer & Feld LLP
  • -
  • USA
  • -
  • December 4 2014

Patent assertion entities (PAEs), sometimes referred to as nonpracticing entities or, derisively, as "patent trolls," generate revenue by acquiring

Antitrust-related recent developments: DOJ settles gun-jumping case, FTC issues fines for failure to submit HSR filing and FTC settles with patent assertion entity

  • Akin Gump Strauss Hauer & Feld LLP
  • -
  • USA
  • -
  • December 4 2014

On Friday, November 7, 2014, two companies agreed to pay $4.95 million to settle U.S. Department of Justice (DOJ) allegations that the companies

N.D. Cal. grants patent holder judgment on the pleadings on Defendants’ antitrust and unfair competition counterclaims with leave to amend

  • Kelley Drye & Warren LLP
  • -
  • USA
  • -
  • November 25 2014

The Northern District of California recently granted judgment on the pleadings in favor of patent-plaintiff ChriMar Systems, Inc. on antitrust and

FTC settlement bars patent troll from using deceptive tactics

  • Heslin Rothenberg Farley & Mesiti PC
  • -
  • USA
  • -
  • November 12 2014

On November 6th, the Federal Trade Commission announced it had settled its first consumer-protection lawsuit against MPHJ Technology Investments, LLC

FTC battles trolls

  • Venable LLP
  • -
  • USA
  • -
  • November 10 2014

Yes, we're a tease. The Bureau Director and Commissioners do not have cameos in next month's final installment of the Hobbit (and no, this is not

Second Circuit rules that foreign anticompetitive use of royalty-free patent is insufficient to establish a domestic effect giving rise to claim under the FTAIA

  • Baker Botts LLP
  • -
  • USA
  • -
  • November 7 2014

Standards essential patents can run afoul of United States antitrust law when the patent owner acts in a matter which creates anticompetitive risks